News Image

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Provided By PR Newswire

Last update: Jan 29, 2025

First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital 

Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies

Read more at prnewswire.com

AETHLON MEDICAL INC

NASDAQ:AEMD (2/21/2025, 8:00:08 PM)

After market: 0.6199 +0.04 (+6.26%)

0.5834

-0.03 (-4.25%)



Find more stocks in the Stock Screener

Follow ChartMill for more